Glympse Bio has developed a liquid biopsy with the potential to diagnose and monitor non-alcoholic steatohepatitis (NASH) with significantly higher accuracy and less invasiveness than needle biopsies, according to a late-breaking presentation at the American Association for the Study of Liver Disease (AASLD) annual The Liver Meeting, held virtually November 12-15. This liquid biopsy uses a panel […]

In the phase 2 RESCUE-ALS clinical trial (NCT04098406), individuals early amyotrophic lateral sclerosis (ALS) who were treated with nanocrystalline gold for 12 weeks had improvement in their Motor Unit Number Index (MUNIX) compared with placebo. In a prespecified subset of participants with limb-onset ALS, MUNIX number and forced vital capacity (FVC) improved after 12 weeks […]

HONOLULU — Researchers in Hawaii are involved in the development of a drug they hope will one day be available to treat Alzheimer’s Disease. The drug is now in clinical trial and patients don’t even have to leave their homes to participate. Millions of people in the U.S. are affected by Alzheimer’s, it’s currently the […]